Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11883 | 30697640 | Biochem Genet | Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells. | 2019 | Details |
| A11884 | 30697502 | Cureus | Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A11885 | 30695042 | PLoS One | Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease. | 2019 | Details |
| A11886 | 30694869 | Am J Gastroenterol | Is Fasting Necessary for Individuals With Nonalcoholic Fatty Liver Disease to Undergo Vibration-Controlled Transient Elastography? | 2019 | Details |
| A11887 | 30694866 | Am J Gastroenterol | Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study. | 2019 | Details |
| A11888 | 30694825 | Curr Opin Endocrinol Diabetes Obes | Dyslipidemia in nonalcoholic fatty liver disease. | 2019 | Details |
| A11889 | 30694445 | Hepatol Int | Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016. | 2019 | Details |
| A11890 | 30692925 | Front Pharmacol | Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues. | 2019 | Details |
| A11891 | 30692555 | Sci Rep | Adiposity in relation to risks of fatty liver, cirrhosis and liver cancer: a prospective study of 0.5 million Chinese adults. | 2019 | Details |
| A11892 | 30691985 | Endocrinol Diabetes Nutr (Engl Ed) | Role of neuropeptide Y gene variant (rs161477) in liver histology in obese patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11893 | 30691359 | Br J Biomed Sci | The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imaging. | 2019 | Details |
| A11894 | 30691143 | Nutrients | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome. | 2019 | Details |
| A11895 | 30690636 | Poult Sci | Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model. | 2019 | Details |
| A11896 | 30690116 | Int J Biol Macromol | Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease. | 2019 | Details |
| A11897 | 30689995 | Eur J Pharmacol | Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease. | 2019 | Details |
| A11898 | 30689994 | Eur J Pharmacol | Evaluating the therapeutic potential of one-carbon donors in nonalcoholic fatty liver disease. | 2019 | Details |
| A11899 | 30689971 | Gastroenterology | Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11900 | 30689650 | PLoS One | Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A11901 | 30687994 | Diabetes Obes Metab | Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial. | 2019 | Details |
| A11902 | 30687780 | Hepatoma Res | Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation. | 2018 | Details |
| A11903 | 30687560 | Precis Clin Med | New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. | 2018 | Details |
| A11904 | 30686897 | World J Gastroenterol | Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies. | 2019 | Details |
| A11905 | 30686780 | Cell Mol Gastroenterol Hepatol | Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism. | 2018 | Details |
| A11906 | 30686716 | Dig Liver Dis | Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women. | 2019 | Details |
| A11907 | 30685917 | Zhonghua Gan Zang Bing Za Zhi | [Prevalence and harm of nonalcoholic fatty liver disease]. | 2019 | Details |
| A11908 | 30685742 | J Pediatr Endocrinol Metab | Hepatopathies in children and adolescents with type 1 diabetes. | 2019 | Details |
| A11910 | 30684890 | Redox Biol | Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity. | 2018 | Details |
| A11911 | 30684076 | Dig Dis Sci | Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus. | 2019 | Details |
| A11912 | 30683985 | Cell Mol Life Sci | The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11914 | 30683615 | Dig Liver Dis | Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2019 | Details |
| A11915 | 30683512 | Surg Obes Relat Dis | Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. | 2018 | Details |
| A11916 | 30683312 | Biochem Biophys Res Commun | Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway. | 2019 | Details |
| A11917 | 30682878 | Medicina (Kaunas) | Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11918 | 30682547 | Nutrition | Raw orange intake is associated with higher prevalence of non-alcoholic fatty liver disease in an adult population. | 2018 | Details |
| A11919 | 30682184 | PLoS One | Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study. | 2019 | Details |
| A11920 | 30681879 | MSMR | Non-alcoholic fatty liver disease (NAFLD), active component, U.S. Armed Forces, 2000-2017. | 2019 | Details |
| A11921 | 30681159 | J Inherit Metab Dis | Choline-related-inherited metabolic diseases-A mini review. | 2019 | Details |
| A11922 | 30680920 | Mol Nutr Food Res | Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice. | 2019 | Details |
| A11923 | 30680827 | Int J Exp Pathol | Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model. | 2019 | Details |
| A11924 | 30680167 | Food Sci Nutr | Anti-fibrotic activity of Euglena gracilis and paramylon in a mouse model of non-alcoholic steatohepatitis. | 2018 | Details |
| A11925 | 30680007 | Exp Ther Med | Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD. | 2018 | Details |
| A11926 | 30680004 | Exp Ther Med | Gemfibrozil reduces lipid accumulation in SMMC-7721 cells via the involvement of PPARα and SREBP1. | 2018 | Details |
| A11927 | 30679317 | Oncologist | Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study. | 2019 | Details |
| A11928 | 30678506 | J Int Med Res | Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease. | 2019 | Details |
| A11930 | 30677224 | Mol Nutr Food Res | Beneficial Effects of Pomegranate on Lipid Metabolism in Metabolic Disorders. | 2019 | Details |
| A11931 | 30677086 | PLoS One | Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. | 2019 | Details |
| A11932 | 30675881 | Food Funct | Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway. | 2019 | Details |
| A11933 | 30675162 | Int J Endocrinol | Relationship of Circulating Fetuin-A Levels with Body Size and Metabolic Phenotypes. | 2018 | Details |
| A11935 | 30674511 | Can Fam Physician | Omega-3 for nonalcoholic fatty liver disease in children. | 2019 | Details |
| A11936 | 30674308 | BMC Med | The association between adherence to the Mediterranean diet and hepatic steatosis: cross-sectional analysis of two independent studies, the UK Fenland Study and the Swiss CoLaus Study. | 2019 | Details |
| A11937 | 30673851 | Med Mol Morphol | The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression. | 2019 | Details |
| A11938 | 30673802 | Diabetologia | The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes. | 2019 | Details |
| A11939 | 30673698 | PLoS One | Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study. | 2019 | Details |
| A11940 | 30673619 | Cell Rep | Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease. | 2019 | Details |
| A11941 | 30673340 | AJR Am J Roentgenol | Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic 18F-FDG PET. | 2019 | Details |
| A11942 | 30673308 | Can J Physiol Pharmacol | The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease. | 2019 | Details |
| A11943 | 30672817 | J Clin Gastroenterol | Among Medicare Patients With Hepatocellular Carcinoma, Non-alcoholic Fatty Liver Disease is the Most Common Etiology and Cause of Mortality. | 2021 | Details |
| A11945 | 30671426 | Front Pediatr | Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11946 | 30671174 | Oxid Med Cell Longev | Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A11947 | 30671129 | Evid Based Complement Alternat Med | Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota. | 2018 | Details |
| A11948 | 30671098 | Lab Anim Res | The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2018 | Details |
| A11949 | 30670963 | Front Pharmacol | The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches. | 2019 | Details |
| A11950 | 30670907 | World J Gastroenterol | Current status, problems, and perspectives of non-alcoholic fatty liver disease research. | 2019 | Details |
| A11951 | 30670819 | Nat Rev Endocrinol | Gut microbial metabolites in obesity, NAFLD and T2DM. | 2019 | Details |
| A11954 | 30669784 | Zhonghua Gan Zang Bing Za Zhi | [Interleukin-17-mediated inflammation promotes nonalcoholic fatty liver disease in mice with regulation of M1-type macrophage polarization]. | 2018 | Details |
| A11955 | 30669332 | Nutrients | Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid. | 2019 | Details |
| A11956 | 30668889 | J Gastroenterol Hepatol | Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis. | 2019 | Details |
| A11957 | 30668625 | Acta Biochim Biophys Sin (Shanghai) | Chronic intermittent hypoxia accelerates liver fibrosis in rats with combined hypoxia and nonalcoholic steatohepatitis via angiogenesis rather than endoplasmic reticulum stress. | 2019 | Details |
| A11958 | 30668424 | Phytomedicine | Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. | 2018 | Details |
| A11959 | 30668392 | Phytomedicine | Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor. | 2018 | Details |
| A11960 | 30667551 | J Gastroenterol Hepatol | Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11961 | 30667502 | JAMA | Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial. | 2019 | Details |
| A11963 | 30666458 | Arch Virol | Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters. | 2019 | Details |
| A11964 | 30666302 | J Hepatocell Carcinoma | Weighing the benefits of hepatocellular carcinoma surveillance against potential harms. | 2019 | Details |
| A11967 | 30664220 | Int J Mol Med | SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway. | 2019 | Details |
| A11968 | 30663454 | Scand J Gastroenterol | Predictive value of the red blood cell distribution width-to-platelet ratio for hepatic fibrosis. | 2019 | Details |
| A11969 | 30663219 | Liver Int | Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. | 2019 | Details |
| A11970 | 30662331 | Int J Med Sci | Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults. | 2019 | Details |
| A11971 | 30661332 | J Exerc Nutrition Biochem | Association of hand-grip strength and non-alcoholic fatty liver disease index in older adults. | 2018 | Details |
| A11972 | 30661330 | J Exerc Nutrition Biochem | Hepatoprotective and anti-obesity effects of Korean blue honeysuckle extracts in high fat diet-fed mice. | 2018 | Details |
| A11973 | 30660906 | Chemosphere | Long-term bisphenol S exposure induces fat accumulation in liver of adult male zebrafish (Danio rerio) and slows yolk lipid consumption in F1 offspring. | 2019 | Details |
| A11974 | 30660825 | Pharmacol Res | Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites. | 2019 | Details |
| A11975 | 30660761 | Diabetes Metab | Insulin resistance and NAFLD: Relationship with intrahepatic iron and serum TNF-α using 1H MR spectroscopy and MRI. | 2019 | Details |
| A11976 | 30660725 | Gastroenterology | Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11978 | 30659956 | Exp Gerontol | Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPARα signaling pathway in cultured hepatocytes. | 2019 | Details |
| A11979 | 30659533 | Curr Pharm Des | Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update. | 2018 | Details |
| A11980 | 30659241 | Sci Rep | A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models. | 2019 | Details |
| A11981 | 30658997 | Gut | Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. | 2019 | Details |
| A11982 | 30658730 | J Hepatol | Fibrosis and alcohol-related liver disease. | 2019 | Details |
| A11983 | 30658519 | Int J Mol Sci | Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. | 2019 | Details |
| A11984 | 30658483 | Nutrients | A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. | 2019 | Details |
| A11985 | 30658440 | Int J Mol Sci | Interactions between Host PPARs and Gut Microbiota in Health and Disease. | 2019 | Details |
| A11986 | 30658094 | Pharmacol Res | Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. | 2019 | Details |
| A11987 | 30657626 | Liver Int | Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis. | 2019 | Details |
| A11990 | 30655210 | Hipertens Riesgo Vasc | [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population]. | 2019 | Details |
| A11991 | 30654845 | Clin Epigenetics | Liver DNA methylation of FADS2 associates with FADS2 genotype. | 2019 | Details |
| A11992 | 30654392 | Semin Liver Dis | NASH in Lean Individuals. | 2019 | Details |
| A11993 | 30653773 | Phytother Res | Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials. | 2019 | Details |
| A11994 | 30653691 | Hepatology | The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11995 | 30653687 | Hepatology | Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Contributes to Hepatic Steatosis. | 2019 | Details |